Choose a language and wait for the translated text.
Shots:
This edition explores Machine Intelligence Meets MedTech: Driving Precision and Performance, examining how artificial intelligence, machine learning, advanced imaging, digital pathology, robotic surgery, connected medical devices, and intelligent clinical workflows are transforming diagnostics, medical interventions, and patient care through greater precision, efficiency, and data-driven decision-making.
Through expert perspectives, feature stories, and industry insights, we examine how AI is strengthening diagnostic accuracy, enabling earlier disease detection, improving pathology and laboratory workflows, supporting clinical decision-making, and advancing intelligent medical technologies, while exploring challenges surrounding clinical validation, algorithmic bias, data integrity, interoperability, cybersecurity, and regulatory oversight.
The issue also features The BioPharma Vanguard, spotlighting Daniel OβDayβs leadership at Gilead Sciences and its expanding therapeutic portfolio; AI Frontiers in Healthcare, showcasing Nabla Bioβs generative AI-powered protein design and next-generation biologics discovery; and Product Spotlight, highlighting FARXIGA (dapagliflozin) and its role in advancing cardiorenal protection and diabetes management.
The post PharmaShots Magazine-Nov-2026 Edition appeared first on PharmaShots.
